nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—schizophrenia—Dimenhydrinate—atopic dermatitis	0.254	0.569	CpDpCtD
Quetiapine—schizophrenia—Diphenhydramine—atopic dermatitis	0.193	0.431	CpDpCtD
Quetiapine—Promazine—Diphenhydramine—atopic dermatitis	0.0404	1	CrCrCtD
Quetiapine—CHRM2—Dimenhydrinate—atopic dermatitis	0.0361	0.112	CbGbCtD
Quetiapine—HRH1—Dimenhydrinate—atopic dermatitis	0.0329	0.102	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0191	0.0592	CbGbCtD
Quetiapine—CYP3A7—Tacrolimus—atopic dermatitis	0.0191	0.0592	CbGbCtD
Quetiapine—CHRM2—Diphenhydramine—atopic dermatitis	0.0176	0.0547	CbGbCtD
Quetiapine—HRH1—Loratadine—atopic dermatitis	0.0161	0.0499	CbGbCtD
Quetiapine—HRH1—Diphenhydramine—atopic dermatitis	0.0161	0.0499	CbGbCtD
Quetiapine—CYP3A5—Tacrolimus—atopic dermatitis	0.0143	0.0444	CbGbCtD
Quetiapine—CYP3A4—Pimecrolimus—atopic dermatitis	0.00938	0.0291	CbGbCtD
Quetiapine—ABCB1—Tacrolimus—atopic dermatitis	0.00931	0.0289	CbGbCtD
Quetiapine—CYP2C19—Loratadine—atopic dermatitis	0.00844	0.0262	CbGbCtD
Quetiapine—CYP2C19—Diphenhydramine—atopic dermatitis	0.00844	0.0262	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00776	0.0241	CbGbCtD
Quetiapine—CYP3A7—Hydrocortisone—atopic dermatitis	0.00776	0.0241	CbGbCtD
Quetiapine—ABCB1—Loratadine—atopic dermatitis	0.00681	0.0212	CbGbCtD
Quetiapine—DRD5—eyelid—atopic dermatitis	0.00645	0.359	CbGeAlD
Quetiapine—CYP2D6—Loratadine—atopic dermatitis	0.00642	0.0199	CbGbCtD
Quetiapine—CYP2D6—Diphenhydramine—atopic dermatitis	0.00642	0.0199	CbGbCtD
Quetiapine—ABCB1—Methylprednisolone—atopic dermatitis	0.00623	0.0193	CbGbCtD
Quetiapine—CYP3A5—Hydrocortisone—atopic dermatitis	0.00582	0.0181	CbGbCtD
Quetiapine—CYP3A4—Tacrolimus—atopic dermatitis	0.00558	0.0173	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00483	0.015	CbGbCtD
Quetiapine—CYP3A7—Dexamethasone—atopic dermatitis	0.00483	0.015	CbGbCtD
Quetiapine—CYP2C19—Prednisone—atopic dermatitis	0.00468	0.0145	CbGbCtD
Quetiapine—CYP3A4—Loratadine—atopic dermatitis	0.00408	0.0127	CbGbCtD
Quetiapine—ABCB1—Betamethasone—atopic dermatitis	0.00405	0.0126	CbGbCtD
Quetiapine—ABCB1—Prednisolone—atopic dermatitis	0.004	0.0124	CbGbCtD
Quetiapine—ABCB1—Hydrocortisone—atopic dermatitis	0.00379	0.0118	CbGbCtD
Quetiapine—ABCB1—Prednisone—atopic dermatitis	0.00377	0.0117	CbGbCtD
Quetiapine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00373	0.0116	CbGbCtD
Quetiapine—CYP3A5—Dexamethasone—atopic dermatitis	0.00362	0.0112	CbGbCtD
Quetiapine—CYP2C19—Dexamethasone—atopic dermatitis	0.00292	0.00907	CbGbCtD
Quetiapine—CYP3A4—Triamcinolone—atopic dermatitis	0.00283	0.00879	CbGbCtD
Quetiapine—CYP3A4—Betamethasone—atopic dermatitis	0.00243	0.00754	CbGbCtD
Quetiapine—CYP3A4—Prednisolone—atopic dermatitis	0.0024	0.00744	CbGbCtD
Quetiapine—ABCB1—Dexamethasone—atopic dermatitis	0.00236	0.00732	CbGbCtD
Quetiapine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00227	0.00705	CbGbCtD
Quetiapine—CYP3A4—Prednisone—atopic dermatitis	0.00226	0.00702	CbGbCtD
Quetiapine—CYP2D6—Dexamethasone—atopic dermatitis	0.00222	0.0069	CbGbCtD
Quetiapine—CHRM5—skin epidermis—atopic dermatitis	0.00181	0.101	CbGeAlD
Quetiapine—CYP3A4—Dexamethasone—atopic dermatitis	0.00141	0.00438	CbGbCtD
Quetiapine—H1F0—neck—atopic dermatitis	0.000747	0.0415	CbGeAlD
Quetiapine—CHRM5—skin of body—atopic dermatitis	0.00056	0.0312	CbGeAlD
Quetiapine—HTR1E—head—atopic dermatitis	0.000533	0.0297	CbGeAlD
Quetiapine—H1F0—skin of body—atopic dermatitis	0.000483	0.0269	CbGeAlD
Quetiapine—CHRM4—head—atopic dermatitis	0.000468	0.026	CbGeAlD
Quetiapine—HTR7—neck—atopic dermatitis	0.000461	0.0256	CbGeAlD
Quetiapine—DRD3—head—atopic dermatitis	0.000435	0.0242	CbGeAlD
Quetiapine—HTR6—head—atopic dermatitis	0.000419	0.0233	CbGeAlD
Quetiapine—DRD5—head—atopic dermatitis	0.000407	0.0227	CbGeAlD
Quetiapine—CHRM5—head—atopic dermatitis	0.000366	0.0203	CbGeAlD
Quetiapine—ADRA1B—head—atopic dermatitis	0.000334	0.0186	CbGeAlD
Quetiapine—ADRA1D—head—atopic dermatitis	0.000327	0.0182	CbGeAlD
Quetiapine—H1F0—head—atopic dermatitis	0.000315	0.0175	CbGeAlD
Quetiapine—DRD1—head—atopic dermatitis	0.000311	0.0173	CbGeAlD
Quetiapine—HTR3A—head—atopic dermatitis	0.000301	0.0167	CbGeAlD
Quetiapine—HTR2A—neck—atopic dermatitis	0.000287	0.016	CbGeAlD
Quetiapine—HTR1B—head—atopic dermatitis	0.000252	0.014	CbGeAlD
Quetiapine—CHRM2—head—atopic dermatitis	0.000251	0.014	CbGeAlD
Quetiapine—HTR1D—head—atopic dermatitis	0.000244	0.0136	CbGeAlD
Quetiapine—HTR2C—head—atopic dermatitis	0.000242	0.0135	CbGeAlD
Quetiapine—CHRM1—head—atopic dermatitis	0.000228	0.0127	CbGeAlD
Quetiapine—CHRM3—head—atopic dermatitis	0.000204	0.0114	CbGeAlD
Quetiapine—HTR1A—head—atopic dermatitis	0.000204	0.0113	CbGeAlD
Quetiapine—HTR7—head—atopic dermatitis	0.000195	0.0108	CbGeAlD
Quetiapine—ADRA1A—head—atopic dermatitis	0.000188	0.0104	CbGeAlD
Quetiapine—DRD2—head—atopic dermatitis	0.000184	0.0102	CbGeAlD
Quetiapine—ADRA2C—head—atopic dermatitis	0.000179	0.00995	CbGeAlD
Quetiapine—HRH1—head—atopic dermatitis	0.000145	0.00808	CbGeAlD
Quetiapine—ADRA2A—head—atopic dermatitis	0.000143	0.00794	CbGeAlD
Quetiapine—HTR2A—head—atopic dermatitis	0.000121	0.00675	CbGeAlD
Quetiapine—CYP2D6—head—atopic dermatitis	0.000111	0.00615	CbGeAlD
Quetiapine—ABCB1—head—atopic dermatitis	7.95e-05	0.00442	CbGeAlD
Quetiapine—Syncope—Methylprednisolone—atopic dermatitis	3.87e-05	0.000321	CcSEcCtD
Quetiapine—Discomfort—Hydrocortisone—atopic dermatitis	3.87e-05	0.00032	CcSEcCtD
Quetiapine—Connective tissue disorder—Prednisone—atopic dermatitis	3.86e-05	0.00032	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisolone—atopic dermatitis	3.84e-05	0.000318	CcSEcCtD
Quetiapine—Vomiting—Tacrolimus—atopic dermatitis	3.82e-05	0.000317	CcSEcCtD
Quetiapine—Loss of consciousness—Triamcinolone—atopic dermatitis	3.8e-05	0.000315	CcSEcCtD
Quetiapine—Loss of consciousness—Methylprednisolone—atopic dermatitis	3.79e-05	0.000315	CcSEcCtD
Quetiapine—Rash—Tacrolimus—atopic dermatitis	3.79e-05	0.000314	CcSEcCtD
Quetiapine—Dermatitis—Tacrolimus—atopic dermatitis	3.79e-05	0.000314	CcSEcCtD
Quetiapine—Shock—Prednisolone—atopic dermatitis	3.78e-05	0.000313	CcSEcCtD
Quetiapine—Cough—Triamcinolone—atopic dermatitis	3.78e-05	0.000313	CcSEcCtD
Quetiapine—Headache—Tacrolimus—atopic dermatitis	3.77e-05	0.000312	CcSEcCtD
Quetiapine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	3.75e-05	0.000311	CcSEcCtD
Quetiapine—Convulsion—Triamcinolone—atopic dermatitis	3.75e-05	0.000311	CcSEcCtD
Quetiapine—Tachycardia—Prednisolone—atopic dermatitis	3.75e-05	0.000311	CcSEcCtD
Quetiapine—Convulsion—Methylprednisolone—atopic dermatitis	3.74e-05	0.00031	CcSEcCtD
Quetiapine—Hypertension—Triamcinolone—atopic dermatitis	3.74e-05	0.00031	CcSEcCtD
Quetiapine—Hypertension—Methylprednisolone—atopic dermatitis	3.73e-05	0.000309	CcSEcCtD
Quetiapine—Infection—Hydrocortisone—atopic dermatitis	3.73e-05	0.000309	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisolone—atopic dermatitis	3.71e-05	0.000308	CcSEcCtD
Quetiapine—Shock—Hydrocortisone—atopic dermatitis	3.69e-05	0.000306	CcSEcCtD
Quetiapine—Myalgia—Triamcinolone—atopic dermatitis	3.68e-05	0.000305	CcSEcCtD
Quetiapine—Nervous system disorder—Hydrocortisone—atopic dermatitis	3.68e-05	0.000305	CcSEcCtD
Quetiapine—Arthralgia—Methylprednisolone—atopic dermatitis	3.68e-05	0.000305	CcSEcCtD
Quetiapine—Myalgia—Methylprednisolone—atopic dermatitis	3.68e-05	0.000305	CcSEcCtD
Quetiapine—Eye disorder—Prednisone—atopic dermatitis	3.67e-05	0.000304	CcSEcCtD
Quetiapine—Anxiety—Methylprednisolone—atopic dermatitis	3.66e-05	0.000304	CcSEcCtD
Quetiapine—Tachycardia—Hydrocortisone—atopic dermatitis	3.66e-05	0.000303	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	3.65e-05	0.000303	CcSEcCtD
Quetiapine—Skin disorder—Hydrocortisone—atopic dermatitis	3.64e-05	0.000302	CcSEcCtD
Quetiapine—Ill-defined disorder—Betamethasone—atopic dermatitis	3.64e-05	0.000302	CcSEcCtD
Quetiapine—Ill-defined disorder—Dexamethasone—atopic dermatitis	3.64e-05	0.000302	CcSEcCtD
Quetiapine—Discomfort—Triamcinolone—atopic dermatitis	3.64e-05	0.000302	CcSEcCtD
Quetiapine—Discomfort—Methylprednisolone—atopic dermatitis	3.63e-05	0.000301	CcSEcCtD
Quetiapine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	3.63e-05	0.000301	CcSEcCtD
Quetiapine—Dry mouth—Triamcinolone—atopic dermatitis	3.6e-05	0.000299	CcSEcCtD
Quetiapine—Angioedema—Betamethasone—atopic dermatitis	3.59e-05	0.000297	CcSEcCtD
Quetiapine—Angioedema—Dexamethasone—atopic dermatitis	3.59e-05	0.000297	CcSEcCtD
Quetiapine—Anorexia—Hydrocortisone—atopic dermatitis	3.57e-05	0.000296	CcSEcCtD
Quetiapine—Nausea—Tacrolimus—atopic dermatitis	3.57e-05	0.000296	CcSEcCtD
Quetiapine—Angiopathy—Prednisone—atopic dermatitis	3.56e-05	0.000295	CcSEcCtD
Quetiapine—Confusional state—Methylprednisolone—atopic dermatitis	3.55e-05	0.000295	CcSEcCtD
Quetiapine—Immune system disorder—Prednisone—atopic dermatitis	3.55e-05	0.000294	CcSEcCtD
Quetiapine—Malaise—Betamethasone—atopic dermatitis	3.54e-05	0.000294	CcSEcCtD
Quetiapine—Malaise—Dexamethasone—atopic dermatitis	3.54e-05	0.000294	CcSEcCtD
Quetiapine—Anaphylactic shock—Triamcinolone—atopic dermatitis	3.53e-05	0.000293	CcSEcCtD
Quetiapine—Vertigo—Dexamethasone—atopic dermatitis	3.53e-05	0.000292	CcSEcCtD
Quetiapine—Vertigo—Betamethasone—atopic dermatitis	3.53e-05	0.000292	CcSEcCtD
Quetiapine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	3.52e-05	0.000292	CcSEcCtD
Quetiapine—Syncope—Dexamethasone—atopic dermatitis	3.52e-05	0.000292	CcSEcCtD
Quetiapine—Syncope—Betamethasone—atopic dermatitis	3.52e-05	0.000292	CcSEcCtD
Quetiapine—Infection—Triamcinolone—atopic dermatitis	3.51e-05	0.000291	CcSEcCtD
Quetiapine—Hypotension—Hydrocortisone—atopic dermatitis	3.5e-05	0.000291	CcSEcCtD
Quetiapine—Infection—Methylprednisolone—atopic dermatitis	3.5e-05	0.00029	CcSEcCtD
Quetiapine—Shock—Triamcinolone—atopic dermatitis	3.47e-05	0.000288	CcSEcCtD
Quetiapine—Insomnia—Prednisolone—atopic dermatitis	3.47e-05	0.000288	CcSEcCtD
Quetiapine—Shock—Methylprednisolone—atopic dermatitis	3.47e-05	0.000287	CcSEcCtD
Quetiapine—Nervous system disorder—Methylprednisolone—atopic dermatitis	3.46e-05	0.000286	CcSEcCtD
Quetiapine—Loss of consciousness—Betamethasone—atopic dermatitis	3.45e-05	0.000286	CcSEcCtD
Quetiapine—Loss of consciousness—Dexamethasone—atopic dermatitis	3.45e-05	0.000286	CcSEcCtD
Quetiapine—Paraesthesia—Prednisolone—atopic dermatitis	3.45e-05	0.000286	CcSEcCtD
Quetiapine—Tachycardia—Triamcinolone—atopic dermatitis	3.45e-05	0.000286	CcSEcCtD
Quetiapine—Mental disorder—Prednisone—atopic dermatitis	3.44e-05	0.000285	CcSEcCtD
Quetiapine—Tachycardia—Methylprednisolone—atopic dermatitis	3.44e-05	0.000285	CcSEcCtD
Quetiapine—Skin disorder—Methylprednisolone—atopic dermatitis	3.42e-05	0.000284	CcSEcCtD
Quetiapine—Malnutrition—Prednisone—atopic dermatitis	3.42e-05	0.000283	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.42e-05	0.000283	CcSEcCtD
Quetiapine—Hyperhidrosis—Triamcinolone—atopic dermatitis	3.41e-05	0.000283	CcSEcCtD
Quetiapine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	3.41e-05	0.000282	CcSEcCtD
Quetiapine—Convulsion—Dexamethasone—atopic dermatitis	3.4e-05	0.000282	CcSEcCtD
Quetiapine—Convulsion—Betamethasone—atopic dermatitis	3.4e-05	0.000282	CcSEcCtD
Quetiapine—Insomnia—Hydrocortisone—atopic dermatitis	3.39e-05	0.000281	CcSEcCtD
Quetiapine—Hypertension—Dexamethasone—atopic dermatitis	3.39e-05	0.000281	CcSEcCtD
Quetiapine—Hypertension—Betamethasone—atopic dermatitis	3.39e-05	0.000281	CcSEcCtD
Quetiapine—Paraesthesia—Hydrocortisone—atopic dermatitis	3.37e-05	0.000279	CcSEcCtD
Quetiapine—Myalgia—Dexamethasone—atopic dermatitis	3.34e-05	0.000277	CcSEcCtD
Quetiapine—Myalgia—Betamethasone—atopic dermatitis	3.34e-05	0.000277	CcSEcCtD
Quetiapine—Anxiety—Dexamethasone—atopic dermatitis	3.33e-05	0.000276	CcSEcCtD
Quetiapine—Anxiety—Betamethasone—atopic dermatitis	3.33e-05	0.000276	CcSEcCtD
Quetiapine—Discomfort—Betamethasone—atopic dermatitis	3.3e-05	0.000274	CcSEcCtD
Quetiapine—Discomfort—Dexamethasone—atopic dermatitis	3.3e-05	0.000274	CcSEcCtD
Quetiapine—Dyspepsia—Hydrocortisone—atopic dermatitis	3.3e-05	0.000274	CcSEcCtD
Quetiapine—Hypotension—Methylprednisolone—atopic dermatitis	3.29e-05	0.000273	CcSEcCtD
Quetiapine—Pain—Prednisolone—atopic dermatitis	3.28e-05	0.000272	CcSEcCtD
Quetiapine—Decreased appetite—Hydrocortisone—atopic dermatitis	3.26e-05	0.00027	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.24e-05	0.000268	CcSEcCtD
Quetiapine—Fatigue—Hydrocortisone—atopic dermatitis	3.23e-05	0.000268	CcSEcCtD
Quetiapine—Vision blurred—Prednisone—atopic dermatitis	3.22e-05	0.000267	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.22e-05	0.000267	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.21e-05	0.000266	CcSEcCtD
Quetiapine—Pain—Hydrocortisone—atopic dermatitis	3.21e-05	0.000266	CcSEcCtD
Quetiapine—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.2e-05	0.000266	CcSEcCtD
Quetiapine—Anaphylactic shock—Betamethasone—atopic dermatitis	3.2e-05	0.000266	CcSEcCtD
Quetiapine—Insomnia—Triamcinolone—atopic dermatitis	3.19e-05	0.000265	CcSEcCtD
Quetiapine—Insomnia—Methylprednisolone—atopic dermatitis	3.19e-05	0.000264	CcSEcCtD
Quetiapine—Infection—Betamethasone—atopic dermatitis	3.18e-05	0.000264	CcSEcCtD
Quetiapine—Infection—Dexamethasone—atopic dermatitis	3.18e-05	0.000264	CcSEcCtD
Quetiapine—Ill-defined disorder—Prednisone—atopic dermatitis	3.17e-05	0.000263	CcSEcCtD
Quetiapine—Paraesthesia—Triamcinolone—atopic dermatitis	3.17e-05	0.000263	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisolone—atopic dermatitis	3.16e-05	0.000262	CcSEcCtD
Quetiapine—Paraesthesia—Methylprednisolone—atopic dermatitis	3.16e-05	0.000262	CcSEcCtD
Quetiapine—Anaemia—Prednisone—atopic dermatitis	3.16e-05	0.000262	CcSEcCtD
Quetiapine—Shock—Betamethasone—atopic dermatitis	3.15e-05	0.000261	CcSEcCtD
Quetiapine—Shock—Dexamethasone—atopic dermatitis	3.15e-05	0.000261	CcSEcCtD
Quetiapine—Dyspnoea—Triamcinolone—atopic dermatitis	3.15e-05	0.000261	CcSEcCtD
Quetiapine—Nervous system disorder—Dexamethasone—atopic dermatitis	3.14e-05	0.000261	CcSEcCtD
Quetiapine—Nervous system disorder—Betamethasone—atopic dermatitis	3.14e-05	0.000261	CcSEcCtD
Quetiapine—Agitation—Prednisone—atopic dermatitis	3.14e-05	0.000261	CcSEcCtD
Quetiapine—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.14e-05	0.00026	CcSEcCtD
Quetiapine—Thrombocytopenia—Betamethasone—atopic dermatitis	3.14e-05	0.00026	CcSEcCtD
Quetiapine—Tachycardia—Betamethasone—atopic dermatitis	3.13e-05	0.000259	CcSEcCtD
Quetiapine—Tachycardia—Dexamethasone—atopic dermatitis	3.13e-05	0.000259	CcSEcCtD
Quetiapine—Angioedema—Prednisone—atopic dermatitis	3.12e-05	0.000259	CcSEcCtD
Quetiapine—Dyspepsia—Triamcinolone—atopic dermatitis	3.11e-05	0.000258	CcSEcCtD
Quetiapine—Dyspepsia—Methylprednisolone—atopic dermatitis	3.1e-05	0.000257	CcSEcCtD
Quetiapine—Hyperhidrosis—Betamethasone—atopic dermatitis	3.1e-05	0.000257	CcSEcCtD
Quetiapine—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.1e-05	0.000257	CcSEcCtD
Quetiapine—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.09e-05	0.000256	CcSEcCtD
Quetiapine—Malaise—Prednisone—atopic dermatitis	3.08e-05	0.000256	CcSEcCtD
Quetiapine—Vertigo—Prednisone—atopic dermatitis	3.07e-05	0.000255	CcSEcCtD
Quetiapine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.07e-05	0.000254	CcSEcCtD
Quetiapine—Syncope—Prednisone—atopic dermatitis	3.07e-05	0.000254	CcSEcCtD
Quetiapine—Anorexia—Dexamethasone—atopic dermatitis	3.05e-05	0.000253	CcSEcCtD
Quetiapine—Anorexia—Betamethasone—atopic dermatitis	3.05e-05	0.000253	CcSEcCtD
Quetiapine—Fatigue—Triamcinolone—atopic dermatitis	3.04e-05	0.000252	CcSEcCtD
Quetiapine—Fatigue—Methylprednisolone—atopic dermatitis	3.04e-05	0.000252	CcSEcCtD
Quetiapine—Pain—Triamcinolone—atopic dermatitis	3.02e-05	0.00025	CcSEcCtD
Quetiapine—Loss of consciousness—Prednisone—atopic dermatitis	3e-05	0.000249	CcSEcCtD
Quetiapine—Hypotension—Dexamethasone—atopic dermatitis	2.99e-05	0.000248	CcSEcCtD
Quetiapine—Hypotension—Betamethasone—atopic dermatitis	2.99e-05	0.000248	CcSEcCtD
Quetiapine—Body temperature increased—Hydrocortisone—atopic dermatitis	2.96e-05	0.000246	CcSEcCtD
Quetiapine—Abdominal pain—Hydrocortisone—atopic dermatitis	2.96e-05	0.000246	CcSEcCtD
Quetiapine—Convulsion—Prednisone—atopic dermatitis	2.96e-05	0.000246	CcSEcCtD
Quetiapine—Hypertension—Prednisone—atopic dermatitis	2.95e-05	0.000245	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	2.92e-05	0.000242	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	2.92e-05	0.000242	CcSEcCtD
Quetiapine—Myalgia—Prednisone—atopic dermatitis	2.91e-05	0.000241	CcSEcCtD
Quetiapine—Arthralgia—Prednisone—atopic dermatitis	2.91e-05	0.000241	CcSEcCtD
Quetiapine—Feeling abnormal—Triamcinolone—atopic dermatitis	2.91e-05	0.000241	CcSEcCtD
Quetiapine—Feeling abnormal—Methylprednisolone—atopic dermatitis	2.9e-05	0.000241	CcSEcCtD
Quetiapine—Anxiety—Prednisone—atopic dermatitis	2.9e-05	0.000241	CcSEcCtD
Quetiapine—Insomnia—Betamethasone—atopic dermatitis	2.9e-05	0.00024	CcSEcCtD
Quetiapine—Insomnia—Dexamethasone—atopic dermatitis	2.9e-05	0.00024	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	2.89e-05	0.00024	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	2.88e-05	0.000239	CcSEcCtD
Quetiapine—Paraesthesia—Betamethasone—atopic dermatitis	2.88e-05	0.000239	CcSEcCtD
Quetiapine—Paraesthesia—Dexamethasone—atopic dermatitis	2.88e-05	0.000239	CcSEcCtD
Quetiapine—Discomfort—Prednisone—atopic dermatitis	2.88e-05	0.000238	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisolone—atopic dermatitis	2.83e-05	0.000235	CcSEcCtD
Quetiapine—Dyspepsia—Dexamethasone—atopic dermatitis	2.82e-05	0.000234	CcSEcCtD
Quetiapine—Dyspepsia—Betamethasone—atopic dermatitis	2.82e-05	0.000234	CcSEcCtD
Quetiapine—Body temperature increased—Triamcinolone—atopic dermatitis	2.79e-05	0.000231	CcSEcCtD
Quetiapine—Anaphylactic shock—Prednisone—atopic dermatitis	2.79e-05	0.000231	CcSEcCtD
Quetiapine—Abdominal pain—Methylprednisolone—atopic dermatitis	2.79e-05	0.000231	CcSEcCtD
Quetiapine—Decreased appetite—Betamethasone—atopic dermatitis	2.79e-05	0.000231	CcSEcCtD
Quetiapine—Decreased appetite—Dexamethasone—atopic dermatitis	2.79e-05	0.000231	CcSEcCtD
Quetiapine—Infection—Prednisone—atopic dermatitis	2.77e-05	0.00023	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	2.77e-05	0.000229	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	2.77e-05	0.000229	CcSEcCtD
Quetiapine—Hypersensitivity—Hydrocortisone—atopic dermatitis	2.76e-05	0.000229	CcSEcCtD
Quetiapine—Fatigue—Dexamethasone—atopic dermatitis	2.76e-05	0.000229	CcSEcCtD
Quetiapine—Fatigue—Betamethasone—atopic dermatitis	2.76e-05	0.000229	CcSEcCtD
Quetiapine—Shock—Prednisone—atopic dermatitis	2.75e-05	0.000228	CcSEcCtD
Quetiapine—Pain—Dexamethasone—atopic dermatitis	2.74e-05	0.000227	CcSEcCtD
Quetiapine—Pain—Betamethasone—atopic dermatitis	2.74e-05	0.000227	CcSEcCtD
Quetiapine—Nervous system disorder—Prednisone—atopic dermatitis	2.74e-05	0.000227	CcSEcCtD
Quetiapine—Tachycardia—Prednisone—atopic dermatitis	2.72e-05	0.000226	CcSEcCtD
Quetiapine—Skin disorder—Prednisone—atopic dermatitis	2.71e-05	0.000225	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisone—atopic dermatitis	2.7e-05	0.000224	CcSEcCtD
Quetiapine—Asthenia—Hydrocortisone—atopic dermatitis	2.69e-05	0.000223	CcSEcCtD
Quetiapine—Anorexia—Prednisone—atopic dermatitis	2.66e-05	0.000221	CcSEcCtD
Quetiapine—Pruritus—Hydrocortisone—atopic dermatitis	2.65e-05	0.00022	CcSEcCtD
Quetiapine—Feeling abnormal—Betamethasone—atopic dermatitis	2.64e-05	0.000219	CcSEcCtD
Quetiapine—Feeling abnormal—Dexamethasone—atopic dermatitis	2.64e-05	0.000219	CcSEcCtD
Quetiapine—Gastrointestinal pain—Betamethasone—atopic dermatitis	2.62e-05	0.000217	CcSEcCtD
Quetiapine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	2.62e-05	0.000217	CcSEcCtD
Quetiapine—Hypersensitivity—Triamcinolone—atopic dermatitis	2.6e-05	0.000216	CcSEcCtD
Quetiapine—Hypersensitivity—Methylprednisolone—atopic dermatitis	2.6e-05	0.000215	CcSEcCtD
Quetiapine—Diarrhoea—Hydrocortisone—atopic dermatitis	2.57e-05	0.000213	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.54e-05	0.000211	CcSEcCtD
Quetiapine—Dizziness—Prednisolone—atopic dermatitis	2.54e-05	0.000211	CcSEcCtD
Quetiapine—Asthenia—Triamcinolone—atopic dermatitis	2.53e-05	0.00021	CcSEcCtD
Quetiapine—Abdominal pain—Dexamethasone—atopic dermatitis	2.53e-05	0.00021	CcSEcCtD
Quetiapine—Body temperature increased—Dexamethasone—atopic dermatitis	2.53e-05	0.00021	CcSEcCtD
Quetiapine—Body temperature increased—Betamethasone—atopic dermatitis	2.53e-05	0.00021	CcSEcCtD
Quetiapine—Abdominal pain—Betamethasone—atopic dermatitis	2.53e-05	0.00021	CcSEcCtD
Quetiapine—Asthenia—Methylprednisolone—atopic dermatitis	2.53e-05	0.00021	CcSEcCtD
Quetiapine—Insomnia—Prednisone—atopic dermatitis	2.52e-05	0.000209	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—atopic dermatitis	2.51e-05	0.000208	CcSEcCtD
Quetiapine—Pruritus—Triamcinolone—atopic dermatitis	2.5e-05	0.000207	CcSEcCtD
Quetiapine—Pruritus—Methylprednisolone—atopic dermatitis	2.49e-05	0.000207	CcSEcCtD
Quetiapine—Dizziness—Hydrocortisone—atopic dermatitis	2.48e-05	0.000206	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—atopic dermatitis	2.46e-05	0.000204	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—atopic dermatitis	2.43e-05	0.000201	CcSEcCtD
Quetiapine—Rash—Prednisolone—atopic dermatitis	2.42e-05	0.000201	CcSEcCtD
Quetiapine—Dermatitis—Prednisolone—atopic dermatitis	2.42e-05	0.000201	CcSEcCtD
Quetiapine—Diarrhoea—Methylprednisolone—atopic dermatitis	2.41e-05	0.0002	CcSEcCtD
Quetiapine—Fatigue—Prednisone—atopic dermatitis	2.41e-05	0.000199	CcSEcCtD
Quetiapine—Headache—Prednisolone—atopic dermatitis	2.41e-05	0.000199	CcSEcCtD
Quetiapine—Constipation—Prednisone—atopic dermatitis	2.39e-05	0.000198	CcSEcCtD
Quetiapine—Vomiting—Hydrocortisone—atopic dermatitis	2.38e-05	0.000198	CcSEcCtD
Quetiapine—Rash—Hydrocortisone—atopic dermatitis	2.36e-05	0.000196	CcSEcCtD
Quetiapine—Dermatitis—Hydrocortisone—atopic dermatitis	2.36e-05	0.000196	CcSEcCtD
Quetiapine—Headache—Hydrocortisone—atopic dermatitis	2.35e-05	0.000195	CcSEcCtD
Quetiapine—Dizziness—Triamcinolone—atopic dermatitis	2.34e-05	0.000194	CcSEcCtD
Quetiapine—Dizziness—Methylprednisolone—atopic dermatitis	2.33e-05	0.000193	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—atopic dermatitis	2.3e-05	0.000191	CcSEcCtD
Quetiapine—Asthenia—Dexamethasone—atopic dermatitis	2.3e-05	0.000191	CcSEcCtD
Quetiapine—Asthenia—Betamethasone—atopic dermatitis	2.3e-05	0.000191	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—atopic dermatitis	2.28e-05	0.000189	CcSEcCtD
Quetiapine—Nausea—Prednisolone—atopic dermatitis	2.28e-05	0.000189	CcSEcCtD
Quetiapine—Pruritus—Betamethasone—atopic dermatitis	2.27e-05	0.000188	CcSEcCtD
Quetiapine—Pruritus—Dexamethasone—atopic dermatitis	2.27e-05	0.000188	CcSEcCtD
Quetiapine—Vomiting—Triamcinolone—atopic dermatitis	2.25e-05	0.000186	CcSEcCtD
Quetiapine—Vomiting—Methylprednisolone—atopic dermatitis	2.24e-05	0.000186	CcSEcCtD
Quetiapine—Nausea—Hydrocortisone—atopic dermatitis	2.23e-05	0.000185	CcSEcCtD
Quetiapine—Rash—Triamcinolone—atopic dermatitis	2.23e-05	0.000185	CcSEcCtD
Quetiapine—Dermatitis—Triamcinolone—atopic dermatitis	2.22e-05	0.000184	CcSEcCtD
Quetiapine—Rash—Methylprednisolone—atopic dermatitis	2.22e-05	0.000184	CcSEcCtD
Quetiapine—Dermatitis—Methylprednisolone—atopic dermatitis	2.22e-05	0.000184	CcSEcCtD
Quetiapine—Headache—Triamcinolone—atopic dermatitis	2.21e-05	0.000183	CcSEcCtD
Quetiapine—Headache—Methylprednisolone—atopic dermatitis	2.21e-05	0.000183	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—atopic dermatitis	2.21e-05	0.000183	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—atopic dermatitis	2.21e-05	0.000183	CcSEcCtD
Quetiapine—Diarrhoea—Dexamethasone—atopic dermatitis	2.19e-05	0.000182	CcSEcCtD
Quetiapine—Diarrhoea—Betamethasone—atopic dermatitis	2.19e-05	0.000182	CcSEcCtD
Quetiapine—Dizziness—Betamethasone—atopic dermatitis	2.12e-05	0.000176	CcSEcCtD
Quetiapine—Dizziness—Dexamethasone—atopic dermatitis	2.12e-05	0.000176	CcSEcCtD
Quetiapine—Nausea—Triamcinolone—atopic dermatitis	2.1e-05	0.000174	CcSEcCtD
Quetiapine—Nausea—Methylprednisolone—atopic dermatitis	2.09e-05	0.000174	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—atopic dermatitis	2.06e-05	0.00017	CcSEcCtD
Quetiapine—Vomiting—Dexamethasone—atopic dermatitis	2.04e-05	0.000169	CcSEcCtD
Quetiapine—Vomiting—Betamethasone—atopic dermatitis	2.04e-05	0.000169	CcSEcCtD
Quetiapine—Rash—Dexamethasone—atopic dermatitis	2.02e-05	0.000168	CcSEcCtD
Quetiapine—Rash—Betamethasone—atopic dermatitis	2.02e-05	0.000168	CcSEcCtD
Quetiapine—Dermatitis—Betamethasone—atopic dermatitis	2.02e-05	0.000167	CcSEcCtD
Quetiapine—Dermatitis—Dexamethasone—atopic dermatitis	2.02e-05	0.000167	CcSEcCtD
Quetiapine—Headache—Betamethasone—atopic dermatitis	2.01e-05	0.000166	CcSEcCtD
Quetiapine—Headache—Dexamethasone—atopic dermatitis	2.01e-05	0.000166	CcSEcCtD
Quetiapine—Asthenia—Prednisone—atopic dermatitis	2e-05	0.000166	CcSEcCtD
Quetiapine—Pruritus—Prednisone—atopic dermatitis	1.97e-05	0.000164	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—atopic dermatitis	1.91e-05	0.000158	CcSEcCtD
Quetiapine—Nausea—Betamethasone—atopic dermatitis	1.9e-05	0.000158	CcSEcCtD
Quetiapine—Nausea—Dexamethasone—atopic dermatitis	1.9e-05	0.000158	CcSEcCtD
Quetiapine—Dizziness—Prednisone—atopic dermatitis	1.85e-05	0.000153	CcSEcCtD
Quetiapine—Vomiting—Prednisone—atopic dermatitis	1.77e-05	0.000147	CcSEcCtD
Quetiapine—Rash—Prednisone—atopic dermatitis	1.76e-05	0.000146	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—atopic dermatitis	1.76e-05	0.000146	CcSEcCtD
Quetiapine—Headache—Prednisone—atopic dermatitis	1.75e-05	0.000145	CcSEcCtD
Quetiapine—Nausea—Prednisone—atopic dermatitis	1.66e-05	0.000137	CcSEcCtD
Quetiapine—CYP3A4—Metabolism—ADSL—atopic dermatitis	5e-06	9.56e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	4.99e-06	9.55e-05	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.97e-06	9.5e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL2—atopic dermatitis	4.95e-06	9.46e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	4.95e-06	9.46e-05	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	4.95e-06	9.46e-05	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	4.92e-06	9.41e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	4.91e-06	9.39e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	4.91e-06	9.38e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	4.9e-06	9.37e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	4.9e-06	9.36e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PPARA—atopic dermatitis	4.89e-06	9.36e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	4.89e-06	9.34e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	4.87e-06	9.31e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	4.87e-06	9.31e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	4.83e-06	9.24e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	4.83e-06	9.22e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	4.81e-06	9.2e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	4.81e-06	9.2e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	4.77e-06	9.11e-05	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	4.75e-06	9.08e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	4.74e-06	9.06e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	4.74e-06	9.05e-05	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	4.73e-06	9.04e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	4.7e-06	8.98e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	4.68e-06	8.94e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	4.67e-06	8.92e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	4.66e-06	8.91e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—MAPK8—atopic dermatitis	4.64e-06	8.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	4.6e-06	8.79e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	4.57e-06	8.74e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	4.56e-06	8.72e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NGF—atopic dermatitis	4.54e-06	8.67e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	4.53e-06	8.65e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.52e-06	8.63e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	4.51e-06	8.62e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	4.49e-06	8.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	4.47e-06	8.55e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	4.47e-06	8.54e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL2—atopic dermatitis	4.46e-06	8.53e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling by GPCR—IL6—atopic dermatitis	4.44e-06	8.49e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	4.41e-06	8.43e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	4.39e-06	8.39e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	4.39e-06	8.39e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	4.37e-06	8.35e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.37e-06	8.34e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.35e-06	8.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PPARA—atopic dermatitis	4.33e-06	8.28e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	4.32e-06	8.26e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	4.32e-06	8.25e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	4.3e-06	8.22e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	4.3e-06	8.22e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.3e-06	8.21e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	4.29e-06	8.21e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	4.29e-06	8.2e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	4.29e-06	8.2e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.29e-06	8.19e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.27e-06	8.17e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	4.27e-06	8.16e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	4.26e-06	8.14e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	4.23e-06	8.09e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	4.22e-06	8.07e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.22e-06	8.06e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	4.21e-06	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.21e-06	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	4.2e-06	8.03e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	4.19e-06	8.02e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	4.18e-06	7.98e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	4.17e-06	7.97e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	4.15e-06	7.94e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	4.14e-06	7.92e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	4.11e-06	7.85e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	4.11e-06	7.85e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	4.11e-06	7.85e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	4.1e-06	7.83e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.08e-06	7.8e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	4.07e-06	7.78e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	4.03e-06	7.7e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	4.02e-06	7.68e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NGF—atopic dermatitis	3.98e-06	7.61e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PPARA—atopic dermatitis	3.98e-06	7.6e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	3.96e-06	7.58e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	3.92e-06	7.49e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NGF—atopic dermatitis	3.91e-06	7.47e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.91e-06	7.47e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	3.9e-06	7.46e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	3.9e-06	7.45e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	3.89e-06	7.44e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	3.88e-06	7.43e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	3.88e-06	7.42e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	3.87e-06	7.41e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	3.87e-06	7.4e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	3.87e-06	7.39e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	3.85e-06	7.36e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	3.85e-06	7.35e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	3.84e-06	7.33e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	3.83e-06	7.32e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	3.82e-06	7.3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	3.81e-06	7.29e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	3.8e-06	7.27e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	3.79e-06	7.25e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	3.79e-06	7.24e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	3.78e-06	7.22e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	3.74e-06	7.15e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.74e-06	7.15e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	3.73e-06	7.14e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	3.73e-06	7.13e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	3.73e-06	7.13e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	3.72e-06	7.11e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	3.72e-06	7.11e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	3.71e-06	7.09e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	3.7e-06	7.06e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	3.66e-06	7e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	3.65e-06	6.98e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PPARA—atopic dermatitis	3.64e-06	6.96e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	3.62e-06	6.92e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	3.6e-06	6.89e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CXCL8—atopic dermatitis	3.6e-06	6.88e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	3.58e-06	6.84e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	3.56e-06	6.81e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	3.56e-06	6.81e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	3.55e-06	6.78e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	3.5e-06	6.69e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	3.47e-06	6.63e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	3.45e-06	6.59e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL2—atopic dermatitis	3.44e-06	6.58e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL2—atopic dermatitis	3.44e-06	6.58e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—IL6—atopic dermatitis	3.43e-06	6.55e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—IL6—atopic dermatitis	3.42e-06	6.54e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL2—atopic dermatitis	3.42e-06	6.53e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	3.4e-06	6.5e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	3.4e-06	6.5e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	3.39e-06	6.48e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL2—atopic dermatitis	3.35e-06	6.4e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	3.33e-06	6.36e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL2—atopic dermatitis	3.29e-06	6.29e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	3.28e-06	6.28e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL6—atopic dermatitis	3.28e-06	6.26e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	3.26e-06	6.22e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	3.25e-06	6.21e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	3.23e-06	6.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.23e-06	6.18e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	3.22e-06	6.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.21e-06	6.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	3.2e-06	6.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	3.17e-06	6.06e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	3.17e-06	6.06e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MAPK8—atopic dermatitis	3.17e-06	6.05e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.16e-06	6.05e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	3.15e-06	6.01e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	3.11e-06	5.95e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.1e-06	5.93e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	3.1e-06	5.92e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	3.08e-06	5.89e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	3.06e-06	5.85e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	3.06e-06	5.85e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	3.03e-06	5.79e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	2.99e-06	5.72e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL2—atopic dermatitis	2.96e-06	5.67e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—atopic dermatitis	2.96e-06	5.66e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	2.95e-06	5.64e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.94e-06	5.62e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL2—atopic dermatitis	2.92e-06	5.59e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	2.92e-06	5.59e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—atopic dermatitis	2.91e-06	5.56e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	2.91e-06	5.56e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	2.86e-06	5.47e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARA—atopic dermatitis	2.82e-06	5.38e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	2.76e-06	5.28e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARA—atopic dermatitis	2.75e-06	5.25e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.73e-06	5.22e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	2.69e-06	5.15e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	2.69e-06	5.15e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	2.67e-06	5.1e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	2.65e-06	5.07e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	2.64e-06	5.05e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	2.63e-06	5.02e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—atopic dermatitis	2.62e-06	5.01e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.59e-06	4.95e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	2.58e-06	4.93e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL2—atopic dermatitis	2.55e-06	4.87e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	2.54e-06	4.86e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	2.54e-06	4.85e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	2.54e-06	4.85e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	2.52e-06	4.82e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	2.47e-06	4.71e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	2.45e-06	4.69e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	2.43e-06	4.65e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	2.43e-06	4.64e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	2.42e-06	4.62e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	2.35e-06	4.48e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	2.34e-06	4.48e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	2.33e-06	4.46e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.3e-06	4.4e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.3e-06	4.4e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.29e-06	4.38e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	2.28e-06	4.37e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	2.27e-06	4.34e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-06	4.32e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-06	4.31e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—atopic dermatitis	2.24e-06	4.28e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	2.23e-06	4.27e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	2.23e-06	4.26e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.2e-06	4.21e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.2e-06	4.2e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.19e-06	4.19e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.19e-06	4.19e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.19e-06	4.18e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	2.18e-06	4.17e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.18e-06	4.17e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	2.17e-06	4.15e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	2.16e-06	4.13e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	2.16e-06	4.12e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	2.15e-06	4.11e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	2.15e-06	4.1e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	2.1e-06	4.01e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.06e-06	3.94e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.03e-06	3.87e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—atopic dermatitis	2.02e-06	3.87e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	2.02e-06	3.87e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—atopic dermatitis	2.02e-06	3.86e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.02e-06	3.85e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	2.01e-06	3.84e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—atopic dermatitis	2.01e-06	3.84e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	2e-06	3.83e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	1.99e-06	3.81e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	1.99e-06	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	1.98e-06	3.79e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—atopic dermatitis	1.97e-06	3.76e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—atopic dermatitis	1.94e-06	3.7e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	1.91e-06	3.65e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.84e-06	3.52e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	1.83e-06	3.5e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—atopic dermatitis	1.74e-06	3.33e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—atopic dermatitis	1.72e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	1.72e-06	3.29e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.69e-06	3.24e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	1.55e-06	2.97e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.5e-06	2.86e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.49e-06	2.85e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	1.45e-06	2.77e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.43e-06	2.73e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.32e-06	2.51e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.29e-06	2.47e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.29e-06	2.47e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.29e-06	2.46e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	1.28e-06	2.45e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	1.27e-06	2.43e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.27e-06	2.42e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.18e-06	2.25e-05	CbGpPWpGaD
